Delivery Order SPE2DH25D0001-SPE2D425F660A
- Not listed
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,130.88 on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. This fixed-price delivery order with economic price adjustment features a completion date of September 3, 2025, and will be performed at Abbott's facility in North Chicago, Illinois. The contract pertains to cartridge analysis and testing components, consistent with Abbott's core business...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,719.63 by the Medical Supply Chain, a defense-focused federal agency, on August 18, 2025. This fixed-price contract with economic price adjustment calls for cartridge chemistry 8-25 test analysis supplies, with performance to be completed at Abbott's facility in North Chicago, Illinois, by September 2, 2025. The contract was awarded on a full and open competition basis with no set-aside...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $1,050.00 on August 12, 2025, by the Medical Supply Chain division of the Department of Defense. This fixed-price delivery order with economic price adjustment will be performed in North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care operations. The contract does not include a set-aside designation, indicating it was awarded through full and open...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a fixed-price delivery order valued at $1,534.09 by the Medical Supply Chain division of the Department of Defense on September 10, 2025, with an ultimate completion date of September 17, 2025. The contract, identified as CRTDG COAG IST PT, will be performed in North Chicago, Illinois, where Abbott maintains its headquarters. This delivery order was issued without a set-aside designation, indicating it was awarded...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order on September 9, 2025, for Chemical 8 Cartridge supplies with a ceiling value of $1,099.50. This fixed-price contract with economic price adjustment was issued with an ultimate completion date of September 11, 2025, and will be performed in North Chicago, Illinois. The award was made without a set-aside designation, indicating full and open competition. The contract is funded by the Defense Medical...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $3,472.50 by the Medical Supply Chain division of the Department of Defense on August 29, 2025, with an ultimate completion date of September 3, 2025. The contract, designated as 4569273740 for a CG8+ Cartridge, utilizes fixed-price pricing with economic price adjustment terms and will be performed in North Chicago, Illinois. This delivery order represents a task order call against a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, has been awarded a delivery order valued at $10,128.58 by the Defense Department's Medical Supply Chain division for performance in North Chicago, Illinois. This fixed-price contract with economic price adjustment provisions was awarded on August 20, 2025, with an ultimate completion date of August 27, 2025. The award represents a child contract with no set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,247.84 on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract, designated as a Fixed Price with Economic Price Adjustment delivery order, calls for the supply of CG8+ cartridges to support federal healthcare operations. The work will be performed in North Chicago, Illinois, with an ultimate completion date of September 8, 2025. This award was...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025, for CHEM 8 Cartridge products. The contract is a fixed-price delivery order with economic price adjustment provisions, valued at $1,412.40, with an ultimate completion date of September 10, 2025. Performance will be executed at Abbott's North Chicago, Illinois facility. This award represents a child contract under a...
- Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $7,845.90 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with completion scheduled for September 4, 2025. The contract covers cartridge chemistry testing and analysis supplies, designated as CRTDG CHM 8 25 TST ANLY, and will be performed at Abbott's North Chicago, Illinois facility. This award was made under firm fixed pricing with no set-aside designation,...
- SPE2DH25D0001Indefinite Delivery Contract
- SPE2DH25D0001-SPE2D425F660ADelivery Order
Abbott Laboratories Inc., through its Abbott Point of Care division, was awarded a delivery order valued at $2,932.00 by the Defense Medical Supply Chain on September 10, 2025, for cartridge chemistry eight twenty-five test analysis supplies. The contract is structured as a fixed price agreement with economic price adjustment provisions and will be performed in North Chicago, Illinois, where Abbott maintains its headquarters and point-of-care operations. This delivery order was awarded without set-aside designation, indicating full and open competition among qualified vendors. The award represents a task order against a larger indefinite delivery vehicle, consistent with Abbott's established presence in federal healthcare procurement through the Department of Veterans Affairs and Defense Logistics Agency. Abbott's substantial experience delivering diagnostic equipment, point-of-care testing devices, and clinical laboratory reagents to federal health systems positions the company to fulfill this specialized testing requirement. The contract is scheduled for completion by September 12, 2025, with performance supporting the government's medical diagnostic and testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 9/10/25 |